Enliven Therapeutics Inc

Research Enliven Therapeutics Inc (ELVN) on Bullrun: market cap USD 3.10B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerELVN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 3.10B
• Financial periodFY2025
• Net income-USD 103.70M
• Free cash flow-USD 70.46M

Valuation Snapshot

latest market cap is USD 3.10B.

About Enliven Therapeutics Inc

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia;

Frequently asked questions

What is Enliven Therapeutics Inc's market cap?

Enliven Therapeutics Inc's market capitalization is USD 3.10B.

What does Enliven Therapeutics Inc do?

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.